Psilocybin is under clinical development by Filament Health and currently in Phase I for Major Depressive Disorder.

Psilocybin is under clinical development by Filament Health and currently in Phase I for Substance (Drug) Abuse.

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

Clinics offering ketamine infusions and injections for “treatment-resistant depression” are today claiming 24-48 hours ...

Glutamatergic medications showed promise in treating obsessive-compulsive and related disorders (OCRDs), especially obsessive ...

Jesse Eisenberg's "A Real Pain," starring Kieran Culkin, is available to rent/purchase on digital platforms. Here's how to ...

The reasons most people hoard is because they have an extreme sentimental attachment to their possessions, or they believe ...

A groundbreaking depression treatment co-pioneered by Queensland researchers using a new form of brain stimulation will begin ...

Award highlights Relief Mental Health's commitment to exceptional patient care and innovative treatments in Red Bank, NJ ...

The sale of antidepressants and mood elevators in India increased significantly, growing by 64% to Rs 2,536 crore since 2020, ...

When a promising medical student was seriously injured in a bus accident, she turned to painting to help cope with the pain ...